A photo of Michael Jordan.

Michael B. Jordan, MD


  • Member, Division of Bone Marrow Transplantation and Immune Deficiency
  • Member, Division of Immunobiology
  • Professor, UC Department of Pediatrics

About

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Prospective two center study of CD38 bright CD8+ effector memory T-cells as a predictor of acute GVHD. Khandelwal, P; Chaturvedi, V; Owsley, E; Efebera, YA; Choe, H; Bostic, M; Kumchala, P; Rajgolikar, G; Ranganathan, P; Garzon, R; et al. Transplantation Reports. 2022; 7.

Quercetin ameliorates XIAP deficiency-associated hyperinflammation. Chiang, SC C; Owsley, E; Panchal, N; Chaturvedi, V; Terrell, CE; Jordan, MB; Mehta, PA; Davies, SM; Akeno, N; Booth, C; et al. Blood. 2022; 140:706-715.

HLH: birds of a feather flock together. Jordan, MB. Blood. 2022; 140:167-168.

P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION. Zoref-Lorenz, A; Murakami, J; Hofstetter, L; Abadi, U; Iyer, S; Mohamed, S; Miller, PG; Natour, AE H; Weinstein, S; Yacobovich, J; et al. HemaSphere. 2022; 6:1089-1090.

Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults. Hines, MR; Von Bahr Greenwood, T; Beutel, G; Beutel, K; Hays, JA; Horne, A; Janka, G; Jordan, MB; Van Laar, JA M; Lachmann, G; et al. Critical Care Medicine. 2022; 50:860-872.

Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model-based approach. Jacqmin, P; Laveille, C; Snoeck, E; Jordan, MB; Locatelli, F; Ballabio, M; de Min, C. British Journal of Clinical Pharmacology. 2022; 88:2128-2139.

A Case of Chronic Lymphocytic Leukemia Complicated by Hemophagocytic Lymphohistiocytosis: Identifying the Aberrant Immune Response. Zoref-Lorenz, A; Yuklea, M; Topaz, G; Jordan, MB; Ellis, M. Journal of General Internal Medicine. 2022; 37:1542-1546.

Malignancy-associated haemophagocytic lymphohistiocytosis. Setiadi, A; Zoref-Lorenz, A; Lee, CY; Jordan, MB; Chen, LY C. The Lancet Haematology. 2022; 9:e217-e227.

An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Zoref-Lorenz, A; Murakami, J; Hofstetter, L; Iyer, S; Alotaibi, AS; Mohamed, SF; Miller, PG; Guber, E; Weinstein, S; Yacobovich, J; et al. Blood. 2022; 139:1098-1110.

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia. Davila Saldana, BJ; John, T; Bonifant, C; Buchbinder, D; Chandra, S; Chandrakasan, S; Chang, W; Chen, L; Elfassy, HL; Geerlinks, AV; et al. Blood Advances. 2022; 6:452-459.

From the Blog


NEJM: Emapalumab Clinical Trial Shows Positive Results Against HLH
Rare Diseases

NEJM: Emapalumab Clinical Trial Shows Positive Results Against HLH

Michael B. Jordan, MD5/7/2020

Breakthrough Therapy Improves Life for Children with LRBA Deficiency
Rare Diseases

Breakthrough Therapy Improves Life for Children with LRBA Deficiency

Michael B. Jordan, MD6/28/2019

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey